Clinical Trials and Case Studies

Editor In Cheif
Sangeeta Singg, PhD

Editor In Chief

About Journal

Clinical Trials and Case Studies journal is an open access, international, peer-reviewed journal that encompasses all aspects of clinical trials. The major sub types of clinical trials are included drug action, prevention, vaccine, screening, emerging, drug discovery and also diagnostic trials. clinical trials and case studies is dedicated for the publishing of articles. Its primary aim is related to medical research methodologies. CTCS also covers scientific areas of case studies in clinical trials, and pleased to invite author, editor and reviewer with a lofty knowledge to show off their work in these platform.

Clinical Trials & Case Studies follows the License and scholars open access publishing policies and the published articles can be accessed online with unique Digital Objective Identifier (DOI) provided by Cross Ref.

Editor-in-Chief’s philosophy
Clinical Trials and Case Studies (CTCS) welcomes all types of research ranging from literature review, case studies, surveys, direct observation, and clinical trials. As long as the researchers follow the ethical and scientific protocol of their discipline and present their findings honestly, objectively, and in an applied manner, their research is considered valuable and contributing. Also, good papers do not need to be written with long-winded accounts and complicated jargon. Dedicated researchers can share and convey their ideas and findings in a parsimonious, concise, and reader-friendly manner. All systematic enquiry (empirical or non-empirical, quantitative or qualitative) has contributory value. As such, the reviewers and editors are expected to be supportive of budding authors and should provide constructive criticism with specific suggestions to improve the submissions. All feedback about manuscript problems should be specific, respectful and suggestive. The bottom line for authors, reviewers, and editors is to help create a least restrictive collegial environment for the scholarly exchange of knowledge and to enjoy the process of dispensing the knowledge worldwide through peer-reviewed publications. As an open access on-line journal, CTCS facilitates an environment in which scholars from multiple disciplines can share their work. We welcome your participation and looking forward to receiving your submissions.

Aim & Scope

Clinical Trials & Case Studies is focussed on publishing manuscripts on various case studies and trials done by different clinical practitioners, researchers, scientists etc. It allows viewers to learn how interesting and challenging cases were assessed and recognized. It gives information about various trials such as double-blind clinical trial, unicenter clinical trial, parallel clinical trial, sequential clinical trial etc, experimented worldwide.




Clinical trials
Diabetic trials
Drug action
Drug delivery
Drug discovery
Emerging drugs
Drug design
Clinical research
Drug clinical trials
Vaccine trials
Prevention trials
Screening trials
Diagnostic trials
Treatment trials

Publication Charges

Ommega Publishers sincerely believes and charges reasonably in other words it is one of the publishers that provides a platform which charges economically towards the publication charges so that there are no barriers for free and fruitful knowledge sharing. Ommega Publishers have also classified their charges as defined by the World Bank Country Classification table: High Income countriesMiddle Income countries and Low Income countries

Ommega journals are Open Access and do not receive any funding, we solely depend on Authors through membership fees, and article processing charges to meet the expenses like managing the team of Editorial experts and professionals to advance and support needs arising in the fields of editorials boards,marketing and IT, peer reviewing of the articles,editing of articles, developing and maintaining the software and information technology, updating the journal website, archiving of the articles and other costs associated concerning to maintain global standards of Publishing.

Ommega publishers believes and maintains high quality of services and articles through this model each and every manuscript that is accepted attract publication charges.Ommega publishers does not support any hidden costs, charge for color figures,as well as does not charge any additional fees for all the authors worldwide.

If for some reason, Researcher/ Author is unable to pay the processing charges, they can submit their applications citing the reasons for a waiver or discount to before or immediately after submitting their article.

Waivers are calculated on the Article processing fees of the related Journal after the submission and acceptance of the manuscript.

"Article Publishing Charges"charged by Ommega Online Publishers for publishing manuscripts are as follows.

Country Fee Description
SC/MR/CR/letters RA
High Income 369 USD 558 USD
Middle Income 270 USD 369 USD
Low Income 225 USD 270 USD

SC=Short communication 
MR=Mini review 
CR= Case report
RA = Review Article/ Research Article
Note:The prices and guidelines mentioned above are subject to change without prior notice.


Clinical trials, Diabetic trials, Drug action, Drug delivery, Drug discovery, Emerging drugs, Drug design, Clinical research, Drug clinical trials, Vaccine trials, Prevention trials, Screening trials, Diagnostic trials, Treatment trials